We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Accurate Diagnosis of Obstetric Cholestasis Prevents Fetal Distress

By Labmedica staff writers
Posted on 06 Mar 2008
Obstetric cholestasis is the most common liver disease during pregnancy and can cause serious complications. More...
It causes an increase in the level of bile acids in the blood, which results in severe itching, particularly on the palms and soles of the feet. Dietary fats are not absorbed properly causing vitamin K levels to drop, increasing the risk of excessive bleeding in the mother and baby. Obstetric cholestasis is linked to fetal distress, premature labor, and stillbirth, and therefore, accurate and timely diagnosis is crucial.

A bile acids test is the most sensitive test for obstetric cholestasis. The bile acids level rises in other conditions, however, such as acute fatty liver of pregnancy, hepatitis, and liver cirrhosis. Therefore, liver function tests such as alanine transaminase (ALT), alkaline phosphatase, and gamma glutamyl transpeptidase (GT) are necessary to rule out the possibility of other liver conditions. Randox Laboratories' (Crumlin, UK) fifth-generation bile acids assay can be used to diagnose obstetric cholestasis, combined with the company's full range of liver function tests

Treatment for obstetric cholestasis involves frequent ultrasound scans to monitor for fetal distress. Rest and periodic liver tests are recommended for the mother and medications can alleviate the symptoms. Delivery is often induced at around 37-38 weeks to reduce the risk of stillbirth. Obstetric cholestasis spontaneously resolves after the baby has been delivered; this is confirmed by bile acid levels returning to normal.


Related Links:
Randox

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.